Literature DB >> 18627093

Effects of plasma exposure on cultured hepatocytes: Implications for bioartificial liver support.

H W Matthew1, J Sternberg, P Stefanovich, J R Morgan, M Toner, R G Tompkins, M L Yarmush.   

Abstract

In order to examine their potential for use in a bioartificial liver, hepatocytes maintained in a collagen sandwich configuration were cultured for 9 days in heparinized rat plasma. The cells exhibited a progressive accumulation of cytoplasmic lipid droplets which proved to be mainly triglyceride (TG). The rate of TG accumulation correlated with the free fatty acid (FFA) content of the plasma. Removal of FFA and TG from plasma by ether extraction significantly reduced the rate and extent of TG accumulation. A smaller reduction in the rate and extent of TG accumulation was observed when cells were maintained in an oxygen enriched environment. The lipid accumulation suppressed urea synthesis, but clearance of the drug diazepam, although constitutively depressed in plasma, appeared unaffected by the accumulation. The functional and morphological effects of plasma exposure could be fully reversed after at least 6 days of plasma exposure by returning the cells to culture medium.The results indicate that elevated FFA in plasma induces lipid accumulation, which inhibits urea synthesis in cultured hepatocytes. This suggests that estimates of the cell number needed for effective liver support should not be based upon function measurements conducted in culture media. Furthermore, optimization of bioartificial liver support device use may have to be governed by the need to limit the plasma exposure of cultured hepatocytes. However, the highly responsive nature of these cultures and the reversibility of the plasma effects suggest that the collagen sandwich culture system is a promising foundation for the development of an effective bioartificial liver support system. (c) 1996 John Wiley & Sons, Inc.

Entities:  

Year:  1996        PMID: 18627093     DOI: 10.1002/(SICI)1097-0290(19960705)51:1<100::AID-BIT12>3.0.CO;2-U

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

Review 1.  Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.

Authors:  Avner Ehrlich; Daniel Duche; Gladys Ouedraogo; Yaakov Nahmias
Journal:  Annu Rev Biomed Eng       Date:  2019-06-04       Impact factor: 9.590

2.  A microfluidic hepatic coculture platform for cell-based drug metabolism studies.

Authors:  Eric Novik; Timothy J Maguire; Piyun Chao; K C Cheng; Martin L Yarmush
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

Review 3.  End-stage liver failure: filling the treatment gap at the intensive care unit.

Authors:  Robert A F M Chamuleau; Ruurdtje Hoekstra
Journal:  J Artif Organs       Date:  2019-09-18       Impact factor: 1.731

Review 4.  Applied Hepatic Bioengineering: Modeling the Human Liver Using Organoid and Liver-on-a-Chip Technologies.

Authors:  Kayque Alves Telles-Silva; Lara Pacheco; Sabrina Komatsu; Fernanda Chianca; Luiz Carlos Caires-Júnior; Bruno Henrique Silva Araujo; Ernesto Goulart; Mayana Zatz
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14

5.  A glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues.

Authors:  Ramkumar Tiruvannamalai-Annamalai; David Randall Armant; Howard W T Matthew
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

Review 6.  Bioengineering considerations in liver regenerative medicine.

Authors:  Ogechi Ogoke; Janet Oluwole; Natesh Parashurama
Journal:  J Biol Eng       Date:  2017-11-26       Impact factor: 4.355

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.